+91-9971016943 info@kamalmedtech.com

INTERVENTIONAL CARDIOLOGY

Drug Eluting Coronary Stent System

Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.

KAMAL MEDTECH

State-of-The-Art Manufacturing Facility for Cardiact Stents.

Kamal has commissioned state-of-the-art manufacturing facility at Delhi NCR. The facility has been built as per International Standard ISO 13485.

Kamal’s dedicated workforce, through Amalgamation of innovation and Technology, has enabled introduction of world class quality Products and Devices which have found ready acceptance and sustained support across a broad spectrum of users worldwide. Our Healthcare vertical is committed to your success with Best in Class Medical Devices and Services.

Your Title Goes Here

Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.

State-of-The-Art Manufacturing Facility
A. R&D: Cutting Edge Research & Technology
B. Quality: World-Class Quality Products & Services
C. Workforce: Kamal’s Dedicated 400+ Workforce
D. Manufacturing Facility: 50,000 Sq. ft State-of-The-Art Manufacturing Facility at Delhi NCR
World’s Best Production & Quality Controlled Equipment
A. Sliding: Tornos Sliding Head Machines
B. Cutting: Laser Cutting System with Power Supply
C. Cleaning: 5 Stage Cleaning Machine
D. Coating: Drug Coating Machine
E. HPLC: HPLC System
License and Certificate
A. ISO 13485
B. CE Certificate

Indian Cardiac Stent Brands

Kamal Medtech, the most trusted Indian Stents Manufacturer has introduced Everoshine, Stenoflex, Trackmaster, and Trackflex Indian Stents Brands that is popular for its innovative design and best clinical outcomes.

Evroshine – Evrolimus Drug Eluting Coronary Stent System

With the edge cutting technology and symmetrically designed, along with added advantage of Everolimus drug, Everoshine – Everolimus Eluting stent system generate less inflammatory response and have more rapid vessel endothelialization which translates into lower rates of myocardial infraction and stent thrombosis.

VIEW PRODUCT

Stenoflex – Sirolimus Drug Eluting
Coronary Stent System

The unique stent design with optimum blend of antiproliferative Sirolimus drug and biodegradable polymers makes, Stenoflex, and ideal stent system with exceptional flexibility and vessel conformance like never before.

VIEW PRODUCT

Trackmaster – Everolimus Drug Eluting
Coronary Stent System

The uniqueness of the product is attributed by its biocompatible Cobalt Chromium alloy (L605) platform, Cytostatic Everolimus Drug, which inhibit cell proliferation, bioresorbable polymers which act as drug binding agents and assist in release of drug in a controlled fashion and PTCA Balloon delivery catheter with ultra-low tip profile for crossing the complex anatomy.

VIEW PRODUCT

Trackflex – Sirolimus Drug Eluting
Coronary Stent System

Trackflex is an epitome of quality and performance. It offers, excellent flexibility, versatile clinical performance, reduces artery injuries, outstanding Sirolimus drug coating characteristics which delivers the drug in the controlled fashion at target site and ultra-thin stent thickness (65 um).

VIEW PRODUCT

Let’s Improve Lives Together

Fine the nearest dealer at your location

[wpforms id=”8548″]

%

Clinical Success Rate

Pan India Partners

Implantations Since 2017

Related Posts

© 2020 Kamal Medtech. All Rights Reserved. Please read the Legal Notice for further details. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Kamal Medtech, its subsidiaries or affiliates. No use of any Kamal Medtech trademark, trade name, or trade dress in this site may be made without the prior written authorization of Kamal Medtech, except to identify the product or services of the company.